1-3 of 3
Jingming Guo
Close
Sort by
Journal Articles

Interim Results of the Launch Study-a Multicenter, Open-Label Study of Selinexor, Dexamethasone and Chemotherapy Drugs in Relapsed/ Refractory Multiple Myeloma

Chunyan Sun, Baijun Fang, Guangxun Gao, Fuling Zhou, Aili He, Fei Zhao, Junying Li, Chun Zhang, Li Weiming, Hui Cheng, Huili Cai, Bin Chen, Jingming Guo, Yu Hu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4763.
https://doi.org/10.1182/blood-2023-186220
Published: 2023
Journal Articles

Preliminary Results from the Launch Study-a Multicenter, Open-Label Study of Selinexor, Dexamethasone and Chemotherapy Drugs in Relapsed/ Refractory Multiple Myeloma

Chunyan Sun, Fei Zhao, Junying Li, Chun Zhang, Weiming Li, Hui Cheng, Huili Cai, Bin Chen, Jingming Guo, Jay Mei, Yu Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12613.
https://doi.org/10.1182/blood-2022-169053
Published: 2022
Journal Articles

The Comparison of Dasatinib 70 Mg/Day to 100 Mg/Day in Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): A Multicenter, Prospective, Randomized Controlled Study

Dan Yu, Zhuangzhi Yang, Hui Cheng, Rui Jiang, Jingming Guo, Chucheng Wan, Jun Qin, Youshan Zhang, Guolin Yuan, Daozi Jiang, Chun Zhang, Fang Liu, Min Zhang, Shiming Chen, Caixia Liang, Jing Zou, Zhiwei Wu, Xiuping Zou, Danlei Han, Xu Chen, Li Wang, Tingting Lv, Xiaolong Tian, Yanping Xie, Hongyu An, Li Yan, Yicheng Zhang, Weiming Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 3615.
https://doi.org/10.1182/blood-2021-148349
Published: 2021